Marker combinations distinguish closely related immune populations by examining cell-surface features together with intracellular signals. This layered view can indicate whether cells are activated, functionally altered, or responding differently within the same sample. As a result, profiling can connect changes in specific cellular states with infection, cancer, autoimmune disorders, or inflammatory disease.
These approaches emphasize different kinds of measurements. Flow cytometry and mass cytometry can characterize populations through combinations of cell-surface and intracellular markers, whereas single-cell sequencing can reveal cell-by-cell differences in gene expression. Choosing among them depends on whether the investigation prioritizes marker-defined populations, signaling-related features, or transcriptional variation.
A sample may contain multiple immune populations with distinct activation states and functional properties, so an overall measurement can conceal meaningful differences between cells. Resolving this heterogeneity helps researchers determine which populations change in disease and whether those changes relate to diagnosis, prognosis, treatment response, or the biological effects of an immunotherapy.
A typical workflow identifies relevant immune populations, measures cell-surface or intracellular markers, and evaluates activation or functional characteristics. Depending on the platform, investigators may also examine gene-expression changes or signaling patterns at the single-cell level. The resulting profile is then compared across health, disease, treatment conditions, or patient groups to identify informative differences.
Its uses extend across infection, cancer, autoimmune disorders, and inflammatory disease. Investigators can apply profiles to discover biomarkers, divide patients into biologically meaningful groups, monitor changes during treatment, and evaluate immunotherapies. These applications are valuable because cellular measurements can link immune-system variation with diagnosis, prognosis, and therapeutic outcomes.
Repeated or comparative profiles can show whether immune populations, activation states, or functional properties change in association with treatment. In immunotherapy studies, these measurements help assess the cellular response to the intervention and identify patterns associated with therapeutic outcomes. Such evidence can contribute to treatment monitoring, biomarker discovery, and patient stratification.